ASX:PTX

Email Alerts for:
ASX:PTX

Prescient Therapeutics (ASX:PTX) - TechKnow Invest Roadshow, August 2023

16 Aug 2023 - Steven Yatomi Clarke - CEO and Managing Director - Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to…

Big gains from tech and consumer discretionary boost ASX 0.05% higher

09 Mar 2023 - Australian shares remained resilient to ex-dividend falls in major companies, including BHP (ASX:BHP), Rio Tinto (ASX:RIO), and CSL (ASX:CSL), as most sectors rose af…

Information Technology lifts ASX 0.1% at noon

09 Mar 2023 - Information Technology has boosted the S&P/ASX 200 0.1 per cent higher at 7311.3 at noon. The reason for this was the announcement from Xero (ASX:XRO), outlining that…

Stocks of the Hour: Prescient Therapeutics, Lindian Resources, Solstice Minerals

09 Mar 2023 - A snapshot of the stocks on the move featuring Prescient Therapeutics (ASX:PTX), Lindian Resources (ASX:LIN) and Solstice Minerals (ASX:SLS).

Prescient Therapeutics (ASX:PTX) - Webinar Presentation

15 Aug 2022 - Steven Yatomi-Clarke – CEO & MD – Prescient Therapeutics is focused on developing novel, personalised therapies for a range of cancers.

Prescient Therapeutics (ASX:PTX) precision oncology medicine

28 May 2019 - Prescient Therapeutics Limited (ASX:PTX) Managing Director & CEO, Steven Yatomi-Clarke discusses the company’s development pipeline, its lead drug candidate PTX-200 a…

Prescient Therapeutics (ASX:PTX) Presentation, FNN Investor Event, May 2019, Sydney

28 May 2019 - Prescient Therapeutics Limited (ASX:PTX) Managing Director & CEO, Steven Yatomi-Clarke discusses the company’s development pipeline, lead drug candidate PTX-200 and P…